ES2561672T8 - Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal - Google Patents

Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal Download PDF

Info

Publication number
ES2561672T8
ES2561672T8 ES11751437.2T ES11751437T ES2561672T8 ES 2561672 T8 ES2561672 T8 ES 2561672T8 ES 11751437 T ES11751437 T ES 11751437T ES 2561672 T8 ES2561672 T8 ES 2561672T8
Authority
ES
Spain
Prior art keywords
cotransport
fluorophosphate
inhibitors
aryl
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11751437.2T
Other languages
English (en)
Other versions
ES2561672T3 (es
Inventor
Brian Peerce
Larry Slomowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DUOPHOS
Original Assignee
DUOPHOS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DUOPHOS filed Critical DUOPHOS
Application granted granted Critical
Publication of ES2561672T3 publication Critical patent/ES2561672T3/es
Publication of ES2561672T8 publication Critical patent/ES2561672T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/146Esters of phosphorous acids containing P-halide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/14Esters of phosphoric acids containing P(=O)-halide groups
    • C07F9/1406Esters of phosphoric acids containing P(=O)-halide groups containing the structure Hal-P(=O)-O-aryl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES11751437.2T 2010-03-05 2011-03-04 Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal Active ES2561672T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31090210P 2010-03-05 2010-03-05
US310902P 2010-03-05
PCT/US2011/027232 WO2011109731A2 (en) 2010-03-05 2011-03-04 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Publications (2)

Publication Number Publication Date
ES2561672T3 ES2561672T3 (es) 2016-02-29
ES2561672T8 true ES2561672T8 (es) 2016-03-11

Family

ID=44542860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11751437.2T Active ES2561672T3 (es) 2010-03-05 2011-03-04 Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal

Country Status (14)

Country Link
US (2) US8921343B2 (es)
EP (1) EP2542560B8 (es)
JP (1) JP5819865B2 (es)
CN (1) CN102918050B (es)
AU (1) AU2011222551B2 (es)
BR (1) BR112012022349B1 (es)
CA (1) CA2792093C (es)
ES (1) ES2561672T3 (es)
HK (1) HK1180692A1 (es)
IL (1) IL221747A (es)
MX (1) MX2012010288A (es)
NZ (1) NZ602703A (es)
RU (1) RU2566757C2 (es)
WO (1) WO2011109731A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542560B8 (en) * 2010-03-05 2015-12-30 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
WO2017111087A1 (ja) * 2015-12-25 2017-06-29 ステラケミファ株式会社 モノフルオロリン酸エステル塩、その製造方法及びフッ素イオン放出性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3213200A (en) * 1999-01-21 2000-08-07 Board Of Regents, The University Of Texas System Inhibitors of intestinal apical membrane na/phosphate co-transportation
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
RU2279676C2 (ru) * 2003-06-16 2006-07-10 Уральская государственная академия ветеринарной медицины Способ контроля над репаративным остеогенезом у животных
US9198923B2 (en) * 2009-01-26 2015-12-01 Opko Ireland Global Holdings, Ltd. Phosphate management with small molecules
EP2542560B8 (en) * 2010-03-05 2015-12-30 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Also Published As

Publication number Publication date
EP2542560B8 (en) 2015-12-30
NZ602703A (en) 2015-01-30
WO2011109731A2 (en) 2011-09-09
BR112012022349A2 (pt) 2016-07-05
US8921343B2 (en) 2014-12-30
JP2013521337A (ja) 2013-06-10
CA2792093C (en) 2018-05-22
WO2011109731A3 (en) 2012-03-01
BR112012022349B1 (pt) 2019-09-24
HK1180692A1 (zh) 2013-10-25
JP5819865B2 (ja) 2015-11-24
AU2011222551B2 (en) 2016-10-06
CN102918050B (zh) 2015-07-01
EP2542560B1 (en) 2015-11-11
CA2792093A1 (en) 2011-09-09
MX2012010288A (es) 2013-02-27
RU2566757C2 (ru) 2015-10-27
RU2012142336A (ru) 2014-04-10
AU2011222551A1 (en) 2012-09-27
EP2542560A4 (en) 2014-10-15
EP2542560A2 (en) 2013-01-09
US20150080597A1 (en) 2015-03-19
US9328128B2 (en) 2016-05-03
ES2561672T3 (es) 2016-02-29
IL221747A (en) 2016-02-29
CN102918050A (zh) 2013-02-06
US20130059822A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
CR20130045A (es) Compuestos terapéuticos
SMT201600464B (it) Procedimento per la preparazione di esterolo
DK2539707T3 (da) Kunstige mycolsyremembraner
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
UY34523A (es) Derivados de betulina
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2958290B1 (fr) Procede de preparation de derives de sulfonamido-benzofurane
IT1402018B1 (it) Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
IT1393136B1 (it) Procedimento per la preparazione del bosentan
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
EA201201667A1 (ru) Способ получения l-аргининовой соли периндоприла
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
IT1403282B1 (it) Procedimento per la preparazione di linagliptin
IT1403244B1 (it) Procedimento per la produzione di lipidi da biomassa.
FR2966150B1 (fr) Procede de preparation de la 2-hydroxybutyrolactone
UY34843A (es) Tratamiento de enfermedades inflamatorias oculares usando laquinimod
UY34286A (es) Diagnóstico de vacuna mejorado
FR2999180B1 (fr) Procede de preparation de sels d'imidazolium dissymetriques
ITTO20121129A1 (it) Procedimento per la protezione di mais.
BR112013032513A2 (pt) adaptador de sistema endoscópico
IT1402029B1 (it) Procedimento per la preparazione di erlotinib